September 2016 Vol. 8 Issue 9

Abstracts & Commentary

Multivitamins and Chronic Disease Risk Reduction

by Douglas MacKay, ND  Do multivitamins decrease your patients’ risk for chronic disease? Will (or should) the answer to this question change your current recommendations?

Nightly Fasting Improves Breast Cancer Prognosis

by Jacob Schor, ND, FABNO  “Eat an early dinner and a late breakfast.” Could this simple recommendation yield life-extending benefits for women with breast cancer?

Food as Medicine in Cardiovascular Disease

by Daniel Chong, ND  Endothelial function may play a more important role than lipoproteins in the pathogenesis of atherosclerosis—if dietary nitrate improves endothelial function, correcting nutrient deficiencies may be addressing the heart of the evolution of CVD.

An Effective, Natural Treatment for GERD: Aloe Vera Syrup

by Devin Wilson, ND  Conventional treatments effectively improve symptoms of GERD. Is aloe vera a reasonable natural treatment option?


Adulterated Ingredients and Products in the Natural Supplements Industry

by Natural Medicine Journal In this interview Mark Blumenthal, founder and executive director of the American Botanical Council, discusses the serious issue of adulteration in the natural products industry. Blumenthal also describes the Botanical Adulterants Program and how it is helping to educate people about this troubling topic.

Healthcare Perspectives

American Association of Naturopathic Physicians 2016 Annual Convention & Exhibition

by Natural Medicine Journal Key takeaways and conference abstracts from this year’s annual AANP convention.

Integrative Health Insights: A Call to Action, Join the Global Movement

by Tabatha Parker, ND  Developing a global perspective that changes you. It is a humbling experience—almost spiritual—as you must learn to surrender, to sit back and listen to other opinions, other perspectives, and other ways of doing things.

Peer-Reviewed Articles

Do Genetics Affect How the Body Uses Fatty Acids?

by Kimberly Sanders, ND  The effects of dietary and supplemental omega-3 and omega-6 fatty acids are varied, and some of this variation may be explained by the genetics of fatty acid metabolism. In particular, the fatty acid desaturase (FADS) enzyme has genetic variation that may influence the rate at which omega-3 and omega-6 precursors are metabolized downstream into long-chain polyunsaturated fatty acids.